Interest Expense in USD of PLUS THERAPEUTICS, INC. from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
PLUS THERAPEUTICS, INC. quarterly/annual Interest Expense history and change rate from Q2 2010 to Q2 2024.
  • PLUS THERAPEUTICS, INC. Interest Expense for the quarter ending 30 Jun 2024 was $27K, a 75.9% decline year-over-year.
  • PLUS THERAPEUTICS, INC. Interest Expense for the twelve months ending 30 Jun 2024 was $210K, a 63.7% decline year-over-year.
  • PLUS THERAPEUTICS, INC. annual Interest Expense for 2023 was $395K, a 44.4% decline from 2022.
  • PLUS THERAPEUTICS, INC. annual Interest Expense for 2022 was $711K, a 23.7% decline from 2021.
  • PLUS THERAPEUTICS, INC. annual Interest Expense for 2021 was $932K, a 15.8% decline from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Change (%)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Change (%)

PLUS THERAPEUTICS, INC. Quarterly Interest Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $210K $27K -$85K -75.9% 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2024
Q1 2024 $295K $34K -$100K -74.6% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2024
Q4 2023 $395K $62K -$97K -61% 01 Oct 2023 31 Dec 2023 10-K 05 Mar 2024
Q3 2023 $492K $87K -$86K -49.7% 01 Jul 2023 30 Sep 2023 10-Q 31 Oct 2023
Q2 2023 $578K $112K -$69K -38.1% 01 Apr 2023 30 Jun 2023 10-Q 14 Aug 2024
Q1 2023 $647K $134K -$64K -32.3% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024
Q4 2022 $711K $159K -$65K -29% 01 Oct 2022 31 Dec 2022 10-K 05 Mar 2024
Q3 2022 $776K $173K -$59K -25.4% 01 Jul 2022 30 Sep 2022 10-Q 31 Oct 2023
Q2 2022 $835K $181K -$48K -21% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023
Q1 2022 $883K $198K -$49K -19.8% 01 Jan 2022 31 Mar 2022 10-Q 20 Apr 2023
Q4 2021 $932K $224K -$29K -11.5% 01 Oct 2021 31 Dec 2021 10-K 23 Feb 2023
Q3 2021 $961K $232K -$21K -8.3% 01 Jul 2021 30 Sep 2021 10-Q 20 Oct 2022
Q2 2021 $982K $229K -$23K -9.13% 01 Apr 2021 30 Jun 2021 10-Q 21 Jul 2022
Q1 2021 $1.01M $247K -$102K -29.2% 01 Jan 2021 31 Mar 2021 10-Q 21 Apr 2022
Q4 2020 $1.11M $253K -$124K -32.9% 01 Oct 2020 31 Dec 2020 10-K 24 Feb 2022
Q3 2020 $1.23M $253K -$113K -30.9% 01 Jul 2020 30 Sep 2020 10-Q 21 Oct 2021
Q2 2020 $1.34M $252K -$345K -57.8% 01 Apr 2020 30 Jun 2020 10-Q 22 Jul 2021
Q1 2020 $1.69M $349K -$166K -32.2% 01 Jan 2020 31 Mar 2020 10-Q 22 Apr 2021
Q4 2019 $1.86M $377K -$165K -30.4% 01 Oct 2019 31 Dec 2019 10-K 22 Feb 2021
Q3 2019 $2.02M $366K -$147K -28.7% 01 Jul 2019 30 Sep 2019 10-Q 22 Oct 2020
Q2 2019 $2.17M $597K +$153K +34.5% 01 Apr 2019 30 Jun 2019 10-Q 10 Aug 2020
Q1 2019 $2.01M $515K +$92K +21.7% 01 Jan 2019 31 Mar 2019 10-Q 14 May 2020
Q4 2018 $1.92M $542K +$96K +21.5% 01 Oct 2018 31 Dec 2018 10-K 30 Mar 2020
Q3 2018 $1.83M $513K +$39K +8.23% 01 Jul 2018 30 Sep 2018 10-Q 14 Nov 2019
Q2 2018 $1.79M $444K -$94K -17.5% 01 Apr 2018 30 Jun 2018 10-Q 15 Aug 2019
Q1 2018 $1.88M $423K -$168K -28.4% 01 Jan 2018 31 Mar 2018 8-K 10 Sep 2019
Q4 2017 $2.05M $446K -$199K -30.9% 01 Oct 2017 31 Dec 2017 8-K 10 Sep 2019
Q3 2017 $2.25M $474K -$171K -26.5% 01 Jul 2017 30 Sep 2017 10-Q 14 Nov 2018
Q2 2017 $2.42M $538K -$107K -16.6% 01 Apr 2017 30 Jun 2017 10-Q 14 Aug 2018
Q1 2017 $2.53M $591K -$66K -10% 01 Jan 2017 31 Mar 2017 10-Q 11 May 2018
Q4 2016 $2.59M $645K -$57K -8.12% 01 Oct 2016 31 Dec 2016 10-K 09 Mar 2018
Q3 2016 $2.65M $645K -$24K -3.59% 01 Jul 2016 30 Sep 2016 10-Q 09 Nov 2017
Q2 2016 $2.67M $645K -$291K -31.1% 01 Apr 2016 30 Jun 2016 10-Q 11 Aug 2017
Q1 2016 $2.96M $657K -$415K -38.7% 01 Jan 2016 31 Mar 2016 10-Q 12 May 2017
Q4 2015 $3.38M $702K -$383K -35.3% 01 Oct 2015 31 Dec 2015 10-K 24 Mar 2017
Q3 2015 $3.76M $669K -$591K -46.9% 01 Jul 2015 30 Sep 2015 10-Q 09 Nov 2016
Q2 2015 $4.35M $936K -$149K -13.7% 01 Apr 2015 30 Jun 2015 10-Q 05 Aug 2016
Q1 2015 $4.5M $1.07M +$131K +13.9% 01 Jan 2015 31 Mar 2015 10-Q 10 May 2016
Q4 2014 $4.37M $1.09M +$144K +15.3% 01 Oct 2014 31 Dec 2014 10-K 11 Mar 2016
Q3 2014 $4.23M $1.26M +$166K +15.2% 01 Jul 2014 30 Sep 2014 10-Q 06 Nov 2015
Q2 2014 $4.06M $1.09M +$433K +66.4% 01 Apr 2014 30 Jun 2014 10-Q 10 Aug 2015
Q1 2014 $3.63M $941K +$232K +32.7% 01 Jan 2014 31 Mar 2014 10-Q 11 May 2015
Q4 2013 $3.4M $941K +$137K +17% 01 Oct 2013 31 Dec 2013 10-K 11 Mar 2016
Q3 2013 $3.26M $1.09M +$237K +27.7% 01 Jul 2013 30 Sep 2013 10-Q 07 Nov 2014
Q2 2013 $3.02M $652K -$208K -24.2% 01 Apr 2013 30 Jun 2013 10-Q 11 Aug 2014
Q1 2013 $3.23M $709K -$156K -18% 01 Jan 2013 31 Mar 2013 10-Q 12 May 2014
Q4 2012 $3.39M $804K -$57K -6.62% 01 Oct 2012 31 Dec 2012 10-K 16 Mar 2015
Q3 2012 $3.44M $857K +$368K +75.3% 01 Jul 2012 30 Sep 2012 10-Q 12 Nov 2013
Q2 2012 $3.08M $860K +$164K +23.6% 01 Apr 2012 30 Jun 2012 10-Q 09 Aug 2013
Q1 2012 $2.91M $865K +$127K +17.2% 01 Jan 2012 31 Mar 2012 10-Q 10 May 2013
Q4 2011 $2.78M $861K 01 Oct 2011 31 Dec 2011 10-K 14 Mar 2014
Q3 2011 $489K -$270K -35.6% 01 Jul 2011 30 Sep 2011 10-Q 09 Nov 2012
Q2 2011 $696K +$442K +174% 01 Apr 2011 30 Jun 2011 10-Q 09 Aug 2012
Q1 2011 $738K 01 Jan 2011 31 Mar 2011 10-Q 10 May 2012
Q3 2010 $759K 01 Jul 2010 30 Sep 2010 10-Q 08 Nov 2011
Q2 2010 $254K 01 Apr 2010 30 Jun 2010 10-Q 09 Aug 2011

PLUS THERAPEUTICS, INC. Annual Interest Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $395K -$316K -44.4% 01 Jan 2023 31 Dec 2023 10-K 05 Mar 2024
2022 $711K -$221K -23.7% 01 Jan 2022 31 Dec 2022 10-K 05 Mar 2024
2021 $932K -$175K -15.8% 01 Jan 2021 31 Dec 2021 10-K 23 Feb 2023
2020 $1.11M -$748K -40.3% 01 Jan 2020 31 Dec 2020 10-K 24 Feb 2022
2019 $1.86M -$67K -3.49% 01 Jan 2019 31 Dec 2019 10-K 22 Feb 2021
2018 $1.92M -$127K -6.2% 01 Jan 2018 31 Dec 2018 10-K 30 Mar 2020
2017 $2.05M -$543K -20.9% 01 Jan 2017 31 Dec 2017 8-K 10 Sep 2019
2016 $2.59M -$787K -23.3% 01 Jan 2016 31 Dec 2016 10-K 09 Mar 2018
2015 $3.38M -$992K -22.7% 01 Jan 2015 31 Dec 2015 10-K 24 Mar 2017
2014 $4.37M +$975K +28.7% 01 Jan 2014 31 Dec 2014 10-K 11 Mar 2016
2013 $3.4M +$10K +0.3% 01 Jan 2013 31 Dec 2013 10-K 11 Mar 2016
2012 $3.39M +$602K +21.6% 01 Jan 2012 31 Dec 2012 10-K 16 Mar 2015
2011 $2.78M +$732K +35.7% 01 Jan 2011 31 Dec 2011 10-K 14 Mar 2014
2010 $2.05M 01 Jan 2010 31 Dec 2010 10-K 15 Mar 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.